Glaxo broadens access to 3TC.
Baker
R
R
D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy*; D018791:CD4 Lymphocyte Count; D006801:Humans; D019259:Lamivudine; D018894:Reverse Transcriptase Inhibitors / Q000600:supply & distribution / Q000627:therapeutic use*; D016047:Zalcitabine / Q000031:analogs & derivatives / Q000600:supply & distribution / Q000627:therapeutic use*
D018894:Reverse Transcriptase Inhibitors; D019259:Lamivudine; D016047:Zalcitabine